

HEAVY METALS may be an impurity the following product types:
mascara (235)
moisturizer (213)
facial moisturizer/treatment (207)
foundation (205)
anti-aging (145)
lipstick (97)
facial powder (92)
eye shadow (91)
sunscreen: makeup (79)
sunscreen: SPF 15-30 (76)
concealer (69)
blush (63)
shampoo (59)
around-eye cream (53)
sunscreen: moisturizer (45)
exfoliant/scrub (39)
facial cleanser (35)
body wash/cleanser (34)
bronzer/highlighter (34)
conditioner (32)
sunscreen: SPF greater than 30 (31)
hair color and bleaching (30)
hand cream (27)
mask (25)
body firming lotion (23)
antiperspirant/deodorant (21)
body oil (20)


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to this ingredient -- not the products containing it -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
| This ingredient: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Contamination concerns |
![]() | Other strong concerns for this ingredient: Occupational hazards |
![]() | Other moderate concerns for this ingredient: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
![]() | Lesser or emerging concerns for this ingredient: Ecotoxicology |
|
See ingredients that may have HEAVY METALS as an impurity See products that may have HEAVY METALS as an impurity | |
| type of concern | product conditions | reference |
| Known human immune system toxicant | National Library of Medicine HazMap | |
| Human skin toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Human skin and immune toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Limited evidence of immune system toxicity | nternational Programme of Chemical Safety Environmental Health Criteria 180, 1996 | |
| Limited evidence of immune system toxicity | A Relational Database of Hazardous Chemicals and Occupational Diseases, 1987 | |
| Human skin and immune toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human immune toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Known human carcinogen | Int'l Agency for Research on Cancer (IARC) - Carcinogens | |
| Cancer - strong evidence | Proposition 65 List of Carcinogens | |
| Limited evidence of carcinogenicity | Int'l Agency for Research on Cancer (IARC) - Carcinogens | |
| Cancer - moderate evidence - hematologic | CHE Toxicant and Disease Database | |
| Cancer - moderate evidence - gastrointestinal | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | Canada - Prohibited and Restricted Cosmetics Ingredients | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | Canada - Prohibited and Restricted Cosmetics Ingredients |
| type of concern | product conditions | reference |
| Human endocrine disruptor - strong evidence | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Strong evidence of human neurotoxicity | CHE Toxicant and Disease Database | |
| Strong evidence of human neurotoxicity | Chemicals known to be neurotoxic to humans | |
| show more | ||
| type of concern | product conditions | reference |
| Possible human developmental toxicant | California EPA Proposition 65 | |
| Human reproductive toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Human developmental toxicant - strong evidence | Proposition 65 List of Carcinogens | |
| Human reproductive toxicant - strong evidence | Proposition 65 List of Carcinogens | |
| Limited evidence of reproductive toxicity | European Union - Classification & Labelling | |
| Limited evidence of reproductive toxicity | National Library of Medicine HazMap | |
| Human reproductive toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human developmental toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human musculoskeletal toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | Chemicals known to be neurotoxic to humans | |
| show more | ||
| type of concern | product conditions | reference |
| Known human renal toxicant | CHE Toxicant and Disease Database | |
| Known human hematologic toxicant | CHE Toxicant and Disease Database | |
| Known human cardiovascular toxicant | CHE Toxicant and Disease Database | |
| Known human respiratory toxicant | products that may be aerosolized (airborne) | CHE Toxicant and Disease Database |
| Known human sense organ toxicant | CHE Toxicant and Disease Database | |
| Known human musculoskeletal toxicant | CHE Toxicant and Disease Database | |
| Known human skin toxicant | CHE Toxicant and Disease Database | |
| Possible human hematologic toxicant | CHE Toxicant and Disease Database | |
| Possible human cardiovascular toxicant | CHE Toxicant and Disease Database | |
| Possible human respiratory toxicant | CHE Toxicant and Disease Database | |
| Possible human renal toxicant | CHE Toxicant and Disease Database | |
| Possible human gastrointestinal toxicant | CHE Toxicant and Disease Database | |
| Possible human sense organ toxicant | products that may be aerosolized (airborne) | CHE Toxicant and Disease Database |
| show more | ||
| type of concern | product conditions | reference |
| Allowed workplace exposures restricted to low doses | European Union - Classification & Labelling |
| type of concern | product conditions | reference |
| Persistent, bioaccumulative in wildlife | EPA PBTs - Waste Minimization Program (RCRA) |
| type of concern | product conditions | reference |
| Cancer - moderate evidence - immune system | CHE Toxicant and Disease Database |
| type of concern | product conditions | reference |
| Wildlife and environmental toxicity | European Union - Classification & Labelling | |
| show more | ||
| type of concern | product conditions | reference |
| 6,234 studies on toxicity in PubMed see search results -> | PubMed |
| type of concern | product conditions | reference |
| Designated as safe for general or specific, limited use in food | FDA Food Additive Status |
| government/industry list/academic study | appears on list as | classification(s) |
| European Union - Classification & Labelling | ARSENIC | •Toxic •Toxic by inhalation and ingestion •Dangerous for the environment •Very toxic to aquatic organisms |
| European Union - Classification & Labelling | MERCURY | •May be toxic to the reproductive system •Very toxic to aquatic organisms |
| FDA Food Additive Status | ARSENIC | • Used in animal feed • Food additive: food additive for which a petition has been filed and a regulation issued • 2 parts per million - As residue in liver and kidney of swine - CFR556.60 • 2 parts per million - As residue in edible bypdts of chickens and turkeys - same Code of Federal Regulations reference as appears earlier in paragraph • 0.5 parts per million - As residue in muscle meat of chickens and turkeys • in eggs • and in muscle meat and by-products (other than kidney and li |
| Canada - Prohibited and Restricted Cosmetics Ingredients | ARSENIC | •Prohibited from use in Canadian cosmetics |
| Canada - Prohibited and Restricted Cosmetics Ingredients | LEAD | •Prohibited from use in Canadian cosmetics |
| Canada - Prohibited and Restricted Cosmetics Ingredients | MERCURY | •Use is restricted in Canadian cosmetics |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: reproductive system toxicity; Condition: abnormal sperm (morphology, motility, and sperm count); Organs/tissues affected: testes |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: renal system toxicity; Condition: acute tubular necrosis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: renal system toxicity; Condition: acute tubular necrosis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: renal system toxicity; Condition: acute tubular necrosis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: ADD/ADHD, hyperactivity; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: hematologic system toxicity; Condition: adult-onset leukemias; Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: skin toxicity; Condition: alopecia (hair loss); Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | LEAD | ALS (Lou Gehrig's disease) - Limited |
| CHE Toxicant and Disease Database | MERCURY | ALS (Lou Gehrig's disease) - Limited |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: altered sex ratio; Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | Altered time to sexual maturation (accelerated or delayed puberty) - Good |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: nervous system toxicity; Condition: Alzheimer's; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: hematologic system toxicity; Condition: anemia (including hemolytic); Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: hematologic system toxicity; Condition: anemia (including hemolytic); Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: anemia (including hemolytic); Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: hematologic system toxicity; Condition: aplastic anemia; Organs/tissues affected: bone marrow |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: aplastic anemia; Organs/tissues affected: bone marrow |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: cardiovascular system toxicity; Condition: arrhythmias; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: cardiovascular system toxicity; Condition: arrhythmias; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: autoimmune antibodies (positive ANA, anti-DNA, RF, etc.); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: behavioral problems; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: behavioral problems; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: renal system toxicity; Condition: bladder cancer; Organs/tissues affected: bladder |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system toxicity; Condition: brain cancer (adult); Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: bronchitis - acute; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: respiratory system toxicity; Condition: bronchitis - chronic; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: endocrine system toxicity; Condition: carcinoid (cancer); Organs/tissues affected: intestines, pancreas, lungs |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: cardiovascular system toxicity; Condition: cardiomyopathy; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: cardiovascular system toxicity; Condition: cardiomyopathy; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: sense organ system toxicity; Condition: cataracts; Organs/tissues affected: eyes |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: cerebral palsy; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: renal system toxicity; Condition: chronic renal disease; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: chronic renal disease; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: gastrointestinal system toxicity; Condition: cirrhosis; Organs/tissues affected: liver |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity, developmental toxicity; Condition: cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/mental retardation/developmental delay; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity, developmental toxicity; Condition: cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/mental retardation/developmental delay; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: nervous system toxicity, developmental toxicity; Condition: cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/mental retardation/developmental delay; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: developmental toxicity; Condition: congenital malformations (birth defects); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: congenital malformations (birth defects); Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: skin toxicity; Condition: contact dermatitis - irritant; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: skin toxicity; Condition: contact dermatitis - irritant; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: respiratory system toxicity; Condition: COPD (chronic obstructive pulmonary disease); Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: cardiovascular system toxicity; Condition: coronary artery disease, peripheral vascular disease, atherosclerosis; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: cardiovascular system toxicity; Condition: coronary artery disease, peripheral vascular disease, atherosclerosis; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: cardiovascular system toxicity; Condition: coronary artery disease, peripheral vascular disease, atherosclerosis; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: musculoskeletal system toxicity, developmental toxicity; Condition: cranio- facial malformations; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: musculoskeletal system toxicity, developmental toxicity; Condition: cranio- facial malformations; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: decreased coordination/ dysequilibrium; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: decreased coordination/ dysequilibrium; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | Decreased vision (includes blindness, retinopathy, optic neuropathy) - Good |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: developmental toxicity; Condition: delayed growth; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: delayed growth; Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: endocrine system toxicity; Condition: diabetes - type II; Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: reproductive system toxicity; Condition: erectile dysfunction; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: erectile dysfunction; Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: reproductive system toxicity; Condition: fetotoxicity (miscarriage/spontaneous abortion, stillbirth); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: reproductive system toxicity; Condition: fetotoxicity (miscarriage/spontaneous abortion, stillbirth); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: fetotoxicity (miscarriage/spontaneous abortion, stillbirth); Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: renal system toxicity, reproductive system toxicity, developmental toxicity; Condition: genito-urinary malformations (includes male and female); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: renal system toxicity; Condition: glomerulonephritis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: glomerulonephritis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: musculoskeletal system toxicity; Condition: gout; Organs/tissues affected: joints |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: sense organ system toxicity; Condition: hearing loss; Organs/tissues affected: ears |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: sense organ system toxicity; Condition: hearing loss; Organs/tissues affected: ears |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: sense organ system toxicity; Condition: hearing loss; Organs/tissues affected: ears |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: gastrointestinal system toxicity; Condition: hepatocellular cancer (liver cancer); Organs/tissues affected: liver |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: gastrointestinal system toxicity; Condition: hepatoportal sclerosis; Organs/tissues affected: liver |
| CHE Toxicant and Disease Database | LEAD | Hormonal changes (levels of circulating sex hormones - FSH/LH, Inhibin, and/or estrogens, progesterones, androgens) - Good |
| CHE Toxicant and Disease Database | MERCURY | Hormonal changes (levels of circulating sex hormones - FSH/LH, Inhibin, and/or estrogens, progesterones, androgens) - Limited |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: skin toxicity; Condition: hyperkeratosis/ hyperpigmentation; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: cardiovascular system toxicity; Condition: hypertension (high blood pressure); Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: cardiovascular system toxicity; Condition: hypertension (high blood pressure); Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: hypertension (high blood pressure); Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: immune system toxicity; Condition: immune suppression; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: immune suppression; Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: immune system toxicity; Condition: immune suppression; Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: developmental toxicity; Condition: low birth weight/small for gestational age/intra-uterine growth retardation; Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: developmental toxicity; Condition: low birth weight/small for gestational age/intra-uterine growth retardation; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: low birth weight/small for gestational age/intra-uterine growth retardation; Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: reproductive system toxicity; Condition: menstrual disorders (abnormal bleeding, short cycles, long cycles, irregular cycles, painful periods); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: menstrual disorders (abnormal bleeding, short cycles, long cycles, irregular cycles, painful periods); Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: ; Condition: metal fume fever; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: Minamata disease; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: hematologic system toxicity; Condition: myelodysplastic syndrome (pre-leukemia); Organs/tissues affected: bone marrow |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: cardiovascular system toxicity; Condition: myocardial infarction (heart attack); Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: myocardial infarction (heart attack); Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: respiratory system toxicity; Condition: nasal septal perforation; Organs/tissues affected: nose |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: renal system toxicity; Condition: nephrotic syndrome; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: renal system toxicity; Condition: nephrotic syndrome; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: nervous system toxicity, developmental toxicity; Condition: neural tube defects/central nervous system malformations; Organs/tissues affected: neural tube |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: nervous system toxicity, developmental toxicity; Condition: neural tube defects/central nervous system malformations; Organs/tissues affected: neural tube |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: nervous system; Condition: neurosthenia (organic affective syndrome); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: nervous system; Condition: neurosthenia (organic affective syndrome); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system; Condition: neurosthenia (organic affective syndrome); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: musculoskeletal system toxicity; Condition: osteoporosis; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: nervous system toxicity; Condition: peripheral neuropathy; Organs/tissues affected: peripheral nervous system |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: peripheral neuropathy; Organs/tissues affected: peripheral nervous system |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: peripheral neuropathy; Organs/tissues affected: peripheral nervous system |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity; Condition: pneumonia; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: pneumonitis (hypersensitivity); Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: respiratory system toxicity; Condition: pneumonitis (hypersensitivity); Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: hematologic system toxicity; Condition: porphyria (toxic); Organs/tissues affected: multiple organs |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: reproductive system toxicity; Condition: pre-term delivery; Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: psychiatric disturbances (disorientation, hallucinations, psychosis, delirium, paranoias, anxiety/depression, emotional laibility, mood changes, euphoria).; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: psychiatric disturbances (disorientation, hallucinations, psychosis, delirium, paranoias, anxiety/depression, emotional laibility, mood changes, euphoria).; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity, cardiovascular system toxicity; Condition: pulmonary edema; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: respiratory system toxicity; Condition: pulmonary fibrosis; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: cardiovascular system toxicity; Condition: Raynaud's phenomenon; Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | LEAD | •Moderate evidence in humans: reproductive system toxicity; Condition: reduced fertility - female (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - female (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: reproductive system toxicity; Condition: reduced fertility - male (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - male (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: musculoskeletal system toxicity, skin toxicity; Condition: scleroderma; Organs/tissues affected: skin, connective tissue |
| CHE Toxicant and Disease Database | LEAD | •Strong evidence in humans: nervous system toxicity; Condition: seizures; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: seizures; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: musculoskeletal system toxicity, developmental toxicity; Condition: skeletal malformations; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | ARSENIC | •Strong evidence in humans: skin toxicity; Condition: skin ulceration; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: spasticity/myoclonus; Organs/tissues affected: |
| CHE Toxicant and Disease Database | ARSENIC | •Moderate evidence in humans: gastrointestinal system toxicity; Condition: steatosis (fatty liver); Organs/tissues affected: liver |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: endocrine system toxicity; Condition: thyroid disorders - hypothyroidism; Organs/tissues affected: thyroid gland |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: endocrine system toxicity; Condition: thyroid disorders - hypothyroidism; Organs/tissues affected: thyroid gland |
| CHE Toxicant and Disease Database | ARSENIC | •Limited evidence in humans: reproductive system toxicity; Condition: uterine cancer; Organs/tissues affected: uterus |
| CHE Toxicant and Disease Database | LEAD | •Limited evidence in humans: renal system toxicity; Condition: Wilm's tumor; Organs/tissues affected: kidney |
| EPA Clean Water Act - Priority Pollutants | ARSENIC | •Priority water pollutant under the Clean Water Act |
| EPA Clean Water Act - Priority Pollutants | LEAD | •Priority water pollutant under the Clean Water Act |
| EPA Clean Water Act - Priority Pollutants | MERCURY | •Priority water pollutant under the Clean Water Act |
| Illinois EPA Chemicals Associated with Endocrine System | LEAD | •EPA: probable endocrine disruptor |
| Illinois EPA Chemicals Associated with Endocrine System | MERCURY | •EPA: probable endocrine disruptor |
| National Library of Medicine HazMap | MERCURY | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Skin Sensitizer - An agent that can induce an allergic reaction in the skin or lungs: Yes; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes; •Restricted - Regulations that have banned or restricted the use of the agent: Paint manufacturers agreed to discontinued the use of mercury in exterior paints after September 1991 and in interior paints after Aug 20, 1990. [ATSDR Case Studies # 17, p. 3]; •Toxic Pneumonitis: Yes; •Nephrotoxin: Yes; •Neurotoxin: Sensorimotor Neuropathy;LC: 11 |
| National Library of Medicine HazMap | LEAD | •Anemia: Anemia, Hemolytic; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes; •Restricted - Regulations that have banned or restricted the use of the agent: Organic lead was added to gasoline in the US until January 1996. Lead allowable in US paint was reduced to 1% in 1971 and to 0.006% in 1977. [ATSDR Case Studies, Lead Toxicity]; •Nephrotoxin: Yes; •Neurotoxin: Motor Neuropathy;PE: 0.05 |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | ARSENIC AND ARSENIC COMPOUNDS | •IARC Group 1: carcinogenic to humans (International Agency for Research on Carcinogens) |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | LEAD | •IARC Group 2B: possible human carcinogen (International Agency for Research on Carcinogens) |
| Chemicals known to be neurotoxic to humans | ARSENIC | •Known to be neurotoxic to humans, suspected developmental neurotoxin |
| Chemicals known to be neurotoxic to humans | LEAD | •Known to be neurotoxic to humans, suspected developmental neurotoxin |
| Chemicals known to be neurotoxic to humans | MERCURY | •Known to be neurotoxic to humans, suspected developmental neurotoxin |
| Our Stolen Future Endocrine Disruptors | ARSENIC | • |
| Our Stolen Future Endocrine Disruptors | LEAD | • |
| Our Stolen Future Endocrine Disruptors | MERCURY | • |
| EPA PBTs - Waste Minimization Program (RCRA) | MERCURY | •Persistent, bioaccumulative toxicant - Resource Conservation and Recovery Act, priority chemical for voluntary waste/emission reductions |
| EPA PBTs - Waste Minimization Program (RCRA) | LEAD | •Persistent, bioaccumulative toxicant - Resource Conservation and Recovery Act, priority chemical for voluntary waste/emission reductions |
| California EPA Proposition 65 | LEAD | •Developmental toxin: California Proposition 65 •Reproductive toxin, female: California Proposition 65 •Reproductive toxin, male: California Proposition 65 |
| Agency for Toxic Substances and Disease Registry, 2004 | ARSENIC | •Gastrointestinal or liver toxicity hazards: suspected |
| Agency for Toxic Substances and Disease Registry, 2004 | ARSENIC | •Skin or sense organ toxicity hazards: suspected |
| Benowitz, N, 1992 | ARSENIC | •Cardiovascular or blood toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1996 | ARSENIC | •Respiratory toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1984 | ARSENIC | •Kidney toxicity hazards: suspected |
| Frazier , L, 1998 | ARSENIC | •Reproductive toxicity hazards: suspected |
| Keith, L, 1997 | ARSENIC | •Endocrine toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | ARSENIC | •Developmental toxicity hazards: recognized |
| Proposition 65 List of Carcinogens | ARSENIC | •Cancer hazards: recognized |
| Benowitz, N, 1992 | LEAD | •Cardiovascular or blood toxicity hazards: suspected |
| Brucker-Davis, F, 1998 | LEAD | •Endocrine toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1996 | LEAD | •Kidney toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1995 | LEAD | •Gastrointestinal or liver toxicity hazards: suspected |
| nternational Programme of Chemical Safety Environmental Health Criteria 180, 1996 | LEAD | •Immunotoxicity hazards: suspected |
| Klaassen, C, 1996 | LEAD | •Skin or sense organ toxicity hazards: suspected |
| Nemery, B, 1990 | LEAD | •Respiratory toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | LEAD | •Developmental toxicity hazards: recognized |
| Proposition 65 List of Carcinogens | LEAD | •Cancer hazards: recognized |
| Proposition 65 List of Carcinogens | LEAD | •Reproductive toxicity hazards: recognized |
| US EPA, 9204 | MERCURY | •Reproductive toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1996 | MERCURY | •Kidney toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1996 | MERCURY | •Skin or sense organ toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1990 | MERCURY | •Respiratory toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1987 | MERCURY | •Immunotoxicity hazards: suspected |
| Illinois EPA, 1997 | MERCURY | •Endocrine toxicity hazards: suspected |
| Klaassen, C, 1996 | MERCURY | •Cardiovascular or blood toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | MERCURY | •Developmental toxicity hazards: recognized |
| National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances, 1995 | MERCURY | •Gastrointestinal or liver toxicity hazards: suspected |
| government/industry list/academic study | reference |
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex I of Directive 67/548/EEC through the 31st ATP. |
| FDA Food Additive Status | FDA (U.S. Food and Drug Administration) 2006. Food Additive Status List. Downloaded from http://www.cfsan.fda.gov/%7Edms/opa-appa.html, Oct 16, 2006. |
| Canada - Prohibited and Restricted Cosmetics Ingredients | Health Canada. 2007. List of Prohibited and Restricted Cosmetic Ingredients. Canada's Cosmetic Ingredient Hotlist. March 2007. |
| CHE Toxicant and Disease Database | CHE (The Collaborative on Health and the Environment). 2006. Toxicant and Disease Database. |
| EPA Clean Water Act - Priority Pollutants | |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| Chemicals known to be neurotoxic to humans | Grandjean P and PJ Landrigan. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 2006 Dec 16;368(9553):2167-78. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| EPA PBTs - Waste Minimization Program (RCRA) | EPA (U.S. Environmental Protection Agency). 1998. Resource Conservatin and Recovery Act (RCRA) Waste Minimization Program - priority chemicals for elimination or reduction. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, DiPalma, J.A., J. Cunningham, J. Herrera, T. McCaffery, and D. Wolf. Occupational and Industrial Toxin Exposures and the Gastrointestinal Tract. American Journal of Gastroenterology. 86(9): 1107-1117. 1991. (Table 2: Selected Agents with Purported Digestive System Injury)., US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995., Zimmerman, H.J. and J.H. Lewis. Chemical- and Toxin-Induced Hepatotoxicity. Gastroenterology Clinics of North America. 24(4): 1027-1045. 1995. (Table 3: Forms of environmental hepatic injury). |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation. |
| Scorecard.org Toxicity Information | Benowitz, N.L. Cardiotoxicity in the Workplace. Occupational Medicine. 7(3): 465-477. 1992. (Table 1: Chemical Toxins and Cardiovascular Disease)., US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Kristensen, T. S. Cardiovascular Diseases and the Work Environment. Scandinavian Journal of Work and Environmental Health. 15:245-264. 1989. (Table 5: Classification of possible risk factors for cardiovascular disease in the work environment)., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995., California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Lu, F.C. Basic Toxicology. 2nd Edition. 1991., Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, Landrigan, P.J., Goyer, R.A. Clarkson, T.W., Sandler, D.P., Smith, J.H., Thun, M.J., and R. Wedeen. The Work-Relatedness of Renal Disease. Archives of Environmental Health. 39(3): 225-230. 1984. (Table 2: Estimated Numbers of Workers in the United States with Potential Occupational Exposures to Known or Suspect Nephrotoxins)., Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm, Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| Scorecard.org Toxicity Information | Benowitz, N.L. Cardiotoxicity in the Workplace. Occupational Medicine. 7(3): 465-477. 1992. (Table 1: Chemical Toxins and Cardiovascular Disease)., US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Kristensen, T. S. Cardiovascular Diseases and the Work Environment. Scandinavian Journal of Work and Environmental Health. 15:245-264. 1989. (Table 5: Classification of possible risk factors for cardiovascular disease in the work environment)., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Brucker-Davis, F. Effects of Environmental Synthetic Chemicals on Thyroid Function. Thyroid. 8(9): 827-856. 1998., Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Landrigan, P.J., Goyer, R.A. Clarkson, T.W., Sandler, D.P., Smith, J.H., Thun, M.J., and R. Wedeen. The Work-Relatedness of Renal Disease. Archives of Environmental Health. 39(3): 225-230. 1984. (Table 2: Estimated Numbers of Workers in the United States with Potential Occupational Exposures to Known or Suspect Nephrotoxins)., Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm, Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | nternational Programme of Chemical Safety Environmental Health Criteria 180. Principles and Methods for Assessing Direct Immunotoxicity Associated with Exposure to Chemicals. World Health Organization. Geneva, 1996. (Table 1: Examples of compounds that are immunotoxic for humans or rodents). |
| Scorecard.org Toxicity Information | Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996. |
| Scorecard.org Toxicity Information | Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online., Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Landrigan, P.J., Goyer, R.A. Clarkson, T.W., Sandler, D.P., Smith, J.H., Thun, M.J., and R. Wedeen. The Work-Relatedness of Renal Disease. Archives of Environmental Health. 39(3): 225-230. 1984. (Table 2: Estimated Numbers of Workers in the United States with Potential Occupational Exposures to Known or Suspect Nephrotoxins)., Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm, Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation. |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Swedish National Chemicals Inspectorate. Labelling of chemical products, Swedish regulations and general advice with regard to the classification and labelling of chemical products hazardous to health, flammables and explosives. List of Allergenic Substances. National Chemicals Inspectorate, Solna, Sweden. 1987, 1990-1992. |
| Scorecard.org Toxicity Information | Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
No items in basket.
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.